SG Americas Securities, LLC
Broker-DealerPosition in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1313360
NEW YORK, NY
Position in AMRX
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$8,836,188
-$1,052,329 QoQ
Shares Held
710,876
-9.4% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SG Americas Securities, LLC holds $233,543,492 across 35 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,812,814 | $65,021,117 | |
| 2 | ZTS |
Zoetis Inc.
|
290,332 | $34,320,145 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
640,179 | $30,824,618 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
780,518 | $23,509,202 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
377,213 | $19,498,139 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
23,113 | $13,705,546 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
710,876 | $8,836,188 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
59,267 | $7,807,834 |
All Filings in AMRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,836,188 | 710,876 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $9,888,517 | 784,803 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $264,864 | 26,460 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $801,953 | 99,129 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $802,477 | 95,761 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $590,182 | 74,518 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $531,182 | 63,844 | Shares | Sole | 2024-10-03 | |
| 2024-03-31 | $121,878 | 20,112 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $102,795 | 16,935 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $221,360 | 52,455 | Shares | Sole | 2023-10-13 | |
| 2023-03-31 | $60,161 | 43,282 | Shares | Sole | 2023-04-28 | |
| 2022-09-30 | $125,730 | 62,243 | Shares | Sole | 2022-10-31 | |
| 2021-12-31 | $74,470 | 15,547 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $208,900 | 39,120 | Shares | Sole | 2021-11-01 | |
| 2021-03-31 | $115,554 | 17,170 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $86,263 | 18,876 | Shares | Sole | 2021-02-04 | |
| 2020-06-30 | $275,637 | 57,907 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $143,362 | 41,196 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||